MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
Status:
Recruiting
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
A prospective, randomized, multicenter, open-label, parallel-arm Study to compare
effectiveness of mycophenolate mofetil versus cyclophosphamide in the Induction Therapy of
pediatric patients with Active Proliferative Lupus Nephritis in Chinese population
Phase:
Phase 4
Details
Lead Sponsor:
Second Xiangya Hospital of Central South University
Collaborators:
Beijing Children's Hospital Children's Hospital of Chongqing Medical University Jiangxi Province Children's Hospital Peking Union Medical College Hospital Shenzhen Children's Hospital The Affiliated Hospital of Qingdao University The Children's Hospital of Zhejiang University School of Medicine The First Affiliated Hospital of Zhengzhou University The Second Hospital of Hebei Medical University